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Abstract With the purpose of facilitating clinical
studies of this infrequent disease, an expert panel
published research criteria for birdshot retinochoroid-
itis (RCBRC). The aim of our study was to investi-
gate the sensitivity of the exclusion criteria of the
RCBRC as applied to all patients seen in our center
with a diagnosis of BRC. This was a single center
retrospective study involving all patients with an
ocular inflammatory disease seen at the Centre for
Ophthalmic Specialized Care, Lausanne, Switzerland,
between 1995 and 2012. The percentage of patients
with a diagnosis of BRC was identified. The exclusion
criteria of the RCBRC were applied to all patients and
the percentage of patients with absence of keratic
precipitates (KPs) and absence of posterior synechiae
were calculated. Out of 1,504 new patients, 25 patients
(1.66 %; 19 female, 6 male) were diagnosed with BRC
and 19 patients had sufficient data to be included in the
study (1.26 %, 13 female). All patients were positive
for HLA-A29 testing. The sensitivity of the RCBRC
with respect to the exclusion criteria applied to our
patient cohort was 84.2 % due to the exclusion of three
patients showing KPs. Our study supports the motion
to re-evaluate the RCBRC, since granulomatous KPs
can be present and are more frequent than previously
estimated and stringent application of the criteria
would lead to a substantial loss of study patients.
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Introduction
Birdshot retinochoroiditis (BRC), described in 1980
by Ryan and Maumenee [1], is a bilateral retinocho-
roidal inflammatory disease without any known sys-
temic involvement. It is a rare disease affecting mainly
Caucasian patients. It has been suggested that this
predilection is due to a higher prevalence of HLA-
A29. The proportion of BRC patients in European and
North American uveitis series is 0.6–1.5 % of uveitis
cases [2–6]. Typically, BRC affects age groups from
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30–70 years with a median age around 50 years and
with a strong gender predilection for women with a
F/M ratio of 3/2 [7].
Histopathology has revealed that the choroidal
stroma is one site of inflammation, while the chorio-
capillaris and the pigment epithelium are intact [8].
The second independent site of inflammation is the
retina, showing a massive vasculitis at the onset of the
disease [8]. The latter histopathological investigation
as well as a recent report did not identify granulom-
atous histological features [9].
With the purpose of facilitating clinical studies of
this infrequent disease, an expert panel published
research criteria for BRC (RCBRC) as a consensus
statement in 2006 [10]. Beside the mandatory bilater-
ality, typical signs for BRC like the presence of at least
three peripapillary ‘birdshot lesions’ inferior or nasal
to the optic disk in one eye need to be met. Further-
more, they proposed two exclusion criteria, both
related to anterior chamber inflammation—keratic
precipitates (KPs) and posterior synechiae (PS).
The aim of our retrospective study was to investi-
gate the sensitivity of the exclusion criteria of the
RCBRC as applied to all patients seen at our center
with a diagnosis of BRC.
Methods
This was a single center retrospective study involving
all patients with an ocular inflammatory disease seen at
the Centre for Ophthalmic Specialized Care, Lausanne,
Switzerland, between 1995 and 2012. All patients
underwent complete routine work-up applied to
patients with posterior uveitis. The study was per-
formed in accordance with the Declaration of Helsinki.
The percentage of patients with a diagnosis of BRC
was identified. Our diagnostic criteria for BRC
included vitreitis and retinal vasculitis in either or
both eyes, visual field anomalies in either or both eyes,
stromal choroiditis as evidenced by indocyanine green
angiography (ICGA) in both eyes and the presence
of HLA-A29. An additional, non-obligatory diagnos-
tic criterion indicating more advanced disease was
the presence of rice-shaped depigmented ‘birdshot
lesions’. The exclusion criteria of the RCBRC were
applied to all patients and the percentage of patients
with absence of KPs and absence of PS were
calculated.
Statistical analysis was performed using the statis-
tics software GraphPad Prism (Version 5.02, Graph-
Pad Software Inc., San Diego, C, USA).
Results
Out of 1,504 new patients with ocular inflammatory
conditions seen between 1995 and 2012, 25 patients
(1.66 %; 19 female, 6 male) were diagnosed with BRC
and 19 patients had sufficient data to be included in the
study (1.26 %, 13 female). All patients were Cauca-
sian. Mean age at onset was 41 ± 4.4 years with a
mean follow-up of 64 ± 38.6 months.
All patients were positive for HLA-A29 testing.
Three out of 19 patients would not be allowed to
be included in a BRC study (15.8 %), although they
had all typical features of BRC. The sensitivity of the
RCBRC with respect to their exclusion criterion as
Table 1 Application of the research criteria for birdshot
retinochoroidits
Patient No. KP PS HLA-A29-
positive
1 No No Yes
2 No No Yes
3 No No Yes
4 No No Yes
5 No No Yes
6 No No Yes
7 No No Yes
8 No No Yes
9 No No Yes
10 No No Yes
11 No No Yes
12 Yes No Yes
13 No No Yes
14 No No Yes
15 No No Yes
16 No No Yes
17 Yes No Yes
18 Yes No Yes
19 No No Yes
Percentage of
patients meeting
the criteria
84.21 % 100 % 100 %
KP keratic precipitate formation, PS posterior synechiae
formation
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applied to our patient cohort was 84.2 % due to the
exclusion of three patients showing KPs (Table 1). On
the other hand, none of our patients developed PS,
representing a highly sensitive criterion in our cohort
(Table 1).
Case reports
Patient 12 presented at the age of 61 years, with onset
7 years earlier. She showed trace anterior cells on both
sides. Two KPs were seen in the left eye which also
showed 2 ? vitreous infiltration. These KPs were seen
while the patient was not yet under treatment. Laser
flare photometry measurements showed 12.7 ph/ms in
the right eye and 9.6 ph/ms in the left eye. On fundus
examination characteristic bilateral oval depigmented
‘birdshot’ lesions could be seen (Fig. 1) associated
with bilateral retinal vasculitis on fluorescein angiog-
raphy (FA) and bilateral typical ICGA signs for
stromal choroiditis including hypofluorescent dark
dots (HDDs), fuzziness of stromal choroidal vessels
and late diffuse choroidal hyperfluorescence in an
HLA-A29-positive patient. The KPs disappeared once
the patient was administered dual inflammation sup-
pressive therapy (IST) consisting of systemic steroids
and cyclosporine.
Patient 17 presented at the age of 54 years, 3 years
after onset of symptoms. Rare cells could be seen in
the anterior chamber with flare values of 12.9 ph/ms in
the right eye and 14.7 ph/ms in the left eye. One single
Fig. 1 Fundus photographs of patients 12 showing typical oval-shaped depigmented fundus lesions distributed in the mid-periphery
Fig. 2 Fundus photographs of patient 17 showing typical oval-shaped depigmented fundus lesions distributed in the mid-periphery
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KP could be seen in her left eye that disappeared after
a subtenon’s injection of triamcinolone acetonide
(40 mg). Vitreous inflammation was graded as
1.5 ? in the right eye and 1 ? in the left eye. On
fundus examination, FA and ICGA, all features typical
of BRC could be identified as in patient 12 (Fig. 2).
Patient 18 presented at the age of 52 years, with an
onset of symptoms one year before. The patient had
been refusing therapy for 3 years. At the time when
two KPs were observed in his left eye (Fig. 2), there
was substantial anterior chamber inflammation present
with flare values of 15.2 ph/ms in the right eye and
15.7 ph/ms in the left eye as well as a 2 ? vitreous
infiltration. On fundus examination, FA and ICGA, all
features typical for BRC could be identified as in the
two previous patients (Fig. 3b). As all other inflam-
matory parameters had also worsened, the patient
finally accepted topical and systemic IST therapy
which led to the disappearance of the KPs.
Discussion
We present here, to the best of our knowledge, the first
report of a considerable proportion of patients with an
obvious diagnosis of BRC, not fitting into the RCBRC
due to the presence of KPs. Furthermore, these KPs
were of the granulomatous type, bringing ‘ipso facto’
BRC into the group of granulomatous uveitis entities.
A more refined and prompt clinical appraisal is
necessary, since BRC is an inflammatory condition
which, if not treated early, has a deleterious prognosis
regarding visual function in a large proportion of
cases. This will be the result of further clinical
research, needing sound international elaborated and
accessible diagnostic criteria for a global audience
[10]. However, these criteria must be phrased with
caution since exclusion criteria will diminish the
already sparse cohorts of patients. The RCBRC report
does not state why they chose the absence of KPs as
one of the ‘sine qua non’ criteria for the diagnosis of
BRC. The reason why granulomatous KPs are rare is
because anterior segment inflammation is very scarce
with low flare values not prone to produce anterior
inflammatory signs such as KPs [11]. We found
three patients out of 19 showing granulomatous KPs
(Fig. 3a), all with the classical fundus appearance, FA
signs and ICGA features of BRC (Figs. 1, 2, and 3b).
Two patients each presented one single granulomatous
KP in one eye and the third patient showed two KPs in
one eye. There was a tendency in all patients to have
higher anterior chamber flare levels than the other
patients of the cohort.
Our three patients with KPs presented with char-
acteristic fundus, ICGA and FA findings of BRC and
were all HLA-A29-positive, excluding other possible
diagnoses.
Uveitis, as proposed by Woods in 1961, is classi-
cally divided into the two main groups—non-granu-
lomatous and granulomatous uveitis [12]. It is a
helpful subdivision in the appraisal of uveitis cases, as
it substantially helps to orient investigations for the
establishment of diagnosis [12]. This terminology is
purely based on clinical signs of inflammation in the
anterior segment and in particular on the type of KPs
on the endothelium. Non-granulomatous uveitis is
characterized by KPs appearing as dust on the
endothelium and includes among others, Behc¸et’s
uveitis and HLA-B27-related uveitis [13, 14]. All
uveitis cases showing KPs that can be individualized
Fig. 3 a Left eye of patient 18 showing one large and one small
granulomatous keratic precipitate. Considering the RCBRC, this
patient, together with patients 12 and 17, would not be allowed
to be included in a study, despite being HLA-B29-positive and
showing all other features of BRC. b Fundus photographs of
patient 18 showing typical oval-shaped depigmented fundus
lesions distributed in the mid-periphery
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should be included in the group of granulomatous
uveitis [15]. The aspect of granulomatous KPs goes
from micro-granulomatous KPs such as in Fuchs’
uveitis to large ‘mutton-fat’ KPs found in ocular
sarcoidosis or tuberculosis [16, 17]. This terminology
is in fact a misnomer as it uses a histological
terminology to design clinical characteristics and
presentations. Similarly when we talk of retinal
vasculitis in a clinical setting this is also a misnomer
as it uses a histological term, vasculitis, to describe
clinical findings of vascular sheathing on fundoscopy
or leaking on fluorescein angiography. The group of
granulomatous diseases includes both histological
granulomatous conditions such as ocular sarcoidosis
or ocular tuberculosis and histological non-granulo-
matous conditions [18]. For Vogt–Koyanagi–Harada
(VKH) disease non-granulomatous histological char-
acteristics as well as granulomatous features were
described depending on the evolutionary stage [19].
Unlike VKH disease, histological data for BRC are
still scarce and histological findings were described as
non-granulomatous in two cases reported to date [9,
12]. For the clinician it is important to understand that
the clinical terms of granulomatous and non-granu-
lomatous are not based on histological criteria but on
clinical signs that go back the 1960s and allow a
clinically meaningful subclassification of uveitis [12].
In conclusion, the presented study supports our
motion to re-evaluate the RCBRC, since KPs can
clearly be found, are granulomatous, and are more
frequent than previously anticipated. Stringent appli-
cation of the criteria would lead to a loss of perfectly
eligible cases. Furthermore, this study provides evi-
dence that BRC is a granulomatous disease and should
be classified as such.
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